243 related articles for article (PubMed ID: 7083207)
1. Aminoglutethimide in the treatment of advanced postmenopausal breast cancer.
Harris AL; Powles TJ; Smith IE
Cancer Res; 1982 Aug; 42(8 Suppl):3405s-3408s. PubMed ID: 7083207
[TBL] [Abstract][Full Text] [Related]
2. Use of aminoglutethimide as second-line endocrine therapy in metastatic breast cancer.
Kaye SB; Woods RL; Fox RM; Coates AS; Tattersall MH
Cancer Res; 1982 Aug; 42(8 Suppl):3445s-3447s. PubMed ID: 6177404
[TBL] [Abstract][Full Text] [Related]
3. Aminoglutethimide for the treatment of advanced postmenopausal breast cancer.
Harris AL; Powles TJ; Smith IE; Coombes RC; Ford HT; Gazet JC; Harmer CL; Morgan M; White H; Parsons CA; McKinna JA
Eur J Cancer Clin Oncol; 1983 Jan; 19(1):11-17. PubMed ID: 6682769
[TBL] [Abstract][Full Text] [Related]
4. Aminoglutethimide in the treatment of metastatic breast cancer.
Troner MB
Cancer Res; 1982 Aug; 42(8 Suppl):3402s-3404s. PubMed ID: 7083206
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma.
Smith IE; Harris AL; Morgan M; Gazet JC; McKinna JA
Cancer Res; 1982 Aug; 42(8 Suppl):3430s-3433s. PubMed ID: 7044525
[TBL] [Abstract][Full Text] [Related]
6. Aminoglutethimide without hydrocortisone in the treatment of postmenopausal patients with advanced breast cancer.
Höffken K; Kempf H; Miller AA; Miller B; Schmidt CG; Faber P; Kley HK
Cancer Treat Rep; 1986 Oct; 70(10):1153-7. PubMed ID: 3756937
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A
Cancer Res; 1982 Aug; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526
[TBL] [Abstract][Full Text] [Related]
8. Aminoglutethimide as second line therapy in advanced breast cancer.
Elomaa I; Blomqvist C; Rissanen P
Breast Cancer Res Treat; 1986; 7 Suppl():S51-4. PubMed ID: 3017481
[TBL] [Abstract][Full Text] [Related]
9. Aminoglutethimide after tamoxifen therapy in advanced breast cancer: M. D. Anderson Hospital experience.
Buzdar AU; Powell KC; Blumenschein GR
Cancer Res; 1982 Aug; 42(8 Suppl):3448s-3450s. PubMed ID: 7083209
[TBL] [Abstract][Full Text] [Related]
10. Low dose aminoglutethimide (125 mg twice daily) with hydrocortisone for the treatment of advanced postmenopausal breast cancer.
Harris AL; Cantwell BM; Sainsbury JR; Needham G; Evans RG; Dawes PJ; Wilson R; Farndon J
Breast Cancer Res Treat; 1986; 7 Suppl():S41-4. PubMed ID: 3742063
[TBL] [Abstract][Full Text] [Related]
11. Treatment of metastatic breast cancer with aminoglutethimide after progression on chemotherapy and/or hormonal therapy with tamoxifen.
Brufman G; Biran S
Eur J Surg Oncol; 1985 Mar; 11(1):27-31. PubMed ID: 2985452
[TBL] [Abstract][Full Text] [Related]
12. Combined endocrine treatment of postmenopausal patients with advanced breast cancer. A randomized trial of tamoxifen vs. tamoxifen plus aminoglutethimide and hydrocortisone.
Rose C; Kamby C; Mouridsen HT; Bastholt L; Brincker H; Skovgaard-Poulsen H; Andersen AP; Loft H; Dombernowsky P; Andersen KW
Breast Cancer Res Treat; 1986; 7 Suppl():S45-50. PubMed ID: 3527306
[TBL] [Abstract][Full Text] [Related]
13. Cross-over comparison of tamoxifen and aminoglutethimide in advanced breast cancer.
Harvey HA; Lipton A; White DS; Santen RJ; Boucher AE; Shafik AS; Dixon RJ
Cancer Res; 1982 Aug; 42(8 Suppl):3451s-3453s. PubMed ID: 6177405
[TBL] [Abstract][Full Text] [Related]
14. [Aminoglutethimide therapy in advanced breast cancer].
Kühböck J; Ludwig H; Pötzi P; Zielinski C
Wien Med Wochenschr; 1985 Dec; 135(23-24):608-11. PubMed ID: 4096007
[TBL] [Abstract][Full Text] [Related]
15. Aminoglutethimide as second line endocrine therapy in advanced breast cancer.
Brufman G; Biran S
Anticancer Res; 1986; 6(5):1065-8. PubMed ID: 3800315
[TBL] [Abstract][Full Text] [Related]
16. Is aminoglutethimide an alternative to adrenalectomy for metastatic carcinoma of the breast?
Sterns EE; Bird CE; Mackie KW
Can J Surg; 1982 Nov; 25(6):695-7. PubMed ID: 7139430
[TBL] [Abstract][Full Text] [Related]
17. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
18. [Aminoglutethimide and aminoglutethimide+tamoxifen treatment for advanced breast cancer].
Hisamatsu K; Nomura Y; Tashiro H
Gan To Kagaku Ryoho; 1992 Oct; 19(12):2017-23. PubMed ID: 1417009
[TBL] [Abstract][Full Text] [Related]
19. Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposure.
Ingle JN; Green SJ; Ahmann DL; Edmonson JH; Nichols WC; Frytak S; Rubin J
Cancer Res; 1982 Aug; 42(8 Suppl):3461s-3467s. PubMed ID: 7044529
[TBL] [Abstract][Full Text] [Related]
20. [The use of aminoglutethimide in the treatment of metastatic breast cancer].
Bellora MG; Ciancio A; Ferrero A; Bergamino T; Zola P; Sismondi P
Minerva Ginecol; 1991 Dec; 43(12):589-93. PubMed ID: 1819778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
